The involvement of myeloperoxidase (MPO) in various inflammatory conditions has been the scope of many recent studies. Besides its well studied catalytic activity, the role of its overall structure and glycosylation pattern in biological function is barely known. 
The involvement of myeloperoxidase (MPO) in various inflammatory conditions has been the scope of many recent studies. Besides its well studied catalytic activity, the role of its overall structure and glycosylation pattern in biological function is barely known. Here, the N-glycan composition of native dimeric human MPO purified from neutrophils and of monomeric MPO recombinantly expressed in Chinese hamster ovary cells has been investigated. Analyses showed the presence of five N-glycans at positions 323, 355, 391, 483, 729 in both proteins. Site by site analysis demonstrated a well conserved microand macroheterogeneity and more complex-type Nglycans for the recombinant form. Comparison of biological functionality of glycosylated and deglycosylated recombinant MPO suggests that glycosylation is required for optimal enzymatic activity. Data are discussed with regard to biosynthesis and three-dimensional structure of MPO.
Myeloperoxidase (MPO, E.C. 1.11.1.7) is a heme-containing glycosylated oxidoreductase that catalyses the production of hypochlorous acid (HOCl) in the presence of hydrogen peroxide (H 2 O 2 ) and chloride anions (1) . The macromolecule is a homodimer with each monomer consisting of a light and a heavy chain. The dimer is stabilized by a disulfide bridge and by several interactions between the carbohydrate moieties located at the dimer interface (2) . MPO is a lysosomal enzyme present in the azurophilic granules of human neutrophils and monocytes and is synthesized in the promyelocytic state during maturation of the polymorphonuclear (PMN) leucocytes (3) .
During phagocytosis of exogenous structures, neutrophils release their granule content (e.g. MPO) into the phagosome. Respiratory burst is initiated by activation of NADPH-oxidase that reduces molecular oxygen and releases superoxide radical anions. Upon superoxide dismutation, hydrogen peroxide is produced that mediates MPO-driven oxidation of chloride to antimicrobial HOCl.
More recent data have indicated that these reactions are not restricted to the phagolysosome. Indeed, under oxidative stress (i.e. excessive and uncontrolled production of various reactive oxygen-derived species, ROS), MPO can escape from neutrophils and circulate in extracellular fluids. Thereby it might cause oxidative modification to host tissues and biomolecules. The potential deleterious effect of this "circulating" MPO has been demonstrated in various pathological conditions involving chronic inflammation, such as atherosclerosis, demyelinating disorders of the central nervous system or end-stage renal disease (4) (5) (6) (7) (8) (9) .
In many of these experiments, recombinant human MPO (r-MPO) expressed in a Chinese hamster ovary (CHO) cell line has been used (10) since recombinant production delivers higher amounts of protein as compared to the classical purification from neutrophils (11) . However, though having the same catalytic activity as the dimeric leukocyte enzyme (h-MPO) (12) (13) (14) , biosynthesis of r-MPO in CHO cell lines lacks some proteolytic steps. As a consequence, r-MPO is monomeric and differs in glycan structure.
Recently Lau et al. (2005) reported the implication of leucocyte MPO in the activation of neutrophils mediated by CD11b/CD18 integrins (15) . Moreover, r-MPO was shown to activate endothelial cells in a proatherogenic process of lipoprotein oxidation (16) . Evidence was provided that the observed phenomena might be correlated with surface structures of both forms of MPO, especially with their glycosylation pattern. This motivated us to comprehensively investigate the glycan structures of h-MPO and r-MPO and their microand macro-heterogeneity. Another aim was to clarify controversial opinions about the number of glycosylation sites in h-MPO and r-MPO. While Johnson et al. (1987) (20) . Finally, the impact of glycosylation on MPO functionality (chlorination activity, LDL oxidation, ROS release from endothelial cells) was investigated.
Experimental procedures
Materials-h-MPO was kindly provided by Zentech (product B-AC-001; Angleur, Belgium) and obtained according to a previously described procedure (11) . Recombinant human MPO (r-MPO) was expressed in a CHO cell line and prepared as previously described (10) . The corresponding protocols for both proteins were detailed in the supporting material section. Each batch was characterized according to its protein concentration (mg/mL), its activity (U/mL) and its specific activity (U/mg). The chlorination activity was determined according to Hewson et al. (1979) (21) . Digestions-N-terminal amino acid sequence determination of MPO was obtained after protein denaturation and SDS/PAGE was performed by the method of Laemmli (1970) (22) . The minislab gel (0.75 × 50 mm) consisted of 7.5 % or 10 % separating gel with a 3.5 % stacking gel. The heaviest bands (94 and 84 kDa) were picked up and analysed by automated Edman's degradation by Eurogentec (Seraing, Belgium). Glycans release from glycoprotein was obtained with PNGase F digestion of glycoprotein and performed on 100 µg of r-MPO and 50 µg of h-MPO according to the manufacturing protocol (Roche Molecular Biochemicals). The released glycans were desalted on column of non-porous graphitized carbon (Alltech, Deerfield, IL), as previously described (22) . Permethylation of N-glycans released by PNGase digestion was carried out with the sodium hydroxide procedure was performed according to Ciucanu and Kerek (1984) (24) . After derivatization, the reaction products were dissolved in 200 µL of methanol and further purified on a C18 Sep-Pak (Waters, Milford, MA). Linkage analysis of N-glycans was endorsed by GC-MS linkage analysis as previously described (25) . Partially methylated alditol acetates, were prepared from permethylated samples. GC-MS analyses were recorded using an Automass II 30 quadrupole mass spectrometer interfaced with a Carlo Erba 8000 Top gas chromatograph (Finnigan, Argenteuil, France). Reduction, alkylation and trypsin hydrolysis of the proteins were carried out on 500 µg of h-MPO or 1 mg of r-MPO according to standard protocols. Proteins were denatured by guanidine, and reduced by dithiothreitol (DTT) (Biorad, Hercules, CA). Alkylation was obtained with iodoacetamide (Biorad) before extensive dialysis against ammonium bicarbonate and lyophilisation. Proteolysis was performed by adding Tos-Phe-CH 2 Cl-treated trypsin (Sigma Chemicals, St Louis, MO) at an enzymesubstrate ratio of 1:50. The tryptic fragments obtained were then purified by C18 Sep-Pak cartridge, eluted with 80% acetonitrile in water containing 0.1% trifluoroacetic acid (TFA) and finally lyophilized. The detailed protocol is available in supporting material section. The purified peptides were ready to be separated either by affinity chromatography using lectincoupled sepharose or by reverse-phase (RP) chromatography. Deglycosylation of recombinant-MPO (~2 mg/mL, deglyMPO) was obtained according to the standard protocol of a glycoprotein deglycosylation Kit (Calbiochem). The protocol was detailed in the supporting material section. Another sample from the same batch was treated similarly but in the absence of any glycosidase (MPO37°). The protein concentration of each sample was measured by the Lowry assay (27) . In order to assess the deglycosylation, the three samples were alkylated, reduced, digested and glycopeptides enriched according to the protocols described above. The peptides were analysed by LC/ESI/(MS)MS with the QTOF6520 (Agilent, Palo Alto, CA, USA). Analytical proceduresEnrichment of glycopeptides was obtained by affinity chromatography on immobilized lectin. The peptide digest was loaded onto a Concanavalin A (Con A)-Sepharose column (Amersham, Pharmacia Biotech, Uppsala, Sweden) and the glycopeptides were enriched by elution with α-methyl-D-glucoside solutions at different concentrations. The protocol was detailed in the supportinf material section. The tryptic digest was separated by RP-HPLC applied to a C18 3.5 µm XTerra column (2.1 x 150 mm) (Waters, Milford, MA) equipped with a guard column Optiguard 1 mm C18 (Interchim, Montluçon, France) and equilibrated with 0.1 % TFA in water. The elution was obtained by a gradient mode with a 0.1 % TFA solution applied for 15 min, followed by a linear gradient of acetonitrile from 0 to 40 % over 90 min, then from 40 to 70 % over 30 min at a flow rate of 0.150 mL/min. Eluates were monitored at 220 nm. Glycopeptide-containing fractions were characterized by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS). PNGase F digestion of tryptic glycopeptides was performed in 50 mM ammonium bicarbonate at 37 °C for 24 h. The products were purified on a C18 Sep-Pak equilibrated in 5 % acetic acid. The PNGase F-released N-glycans and peptides were lyophilized. The glycans were further permethylated as described above. SDS-PAGE of MPO was carried out on an aliquot that was denatured in Laemmli buffer (22) at 100 °C for 5 min and run on 10 % acrylamide gel (Acrylamide/Bis-acrylamide, 29:1 ratio). Electrophoresis was conducted using Mini-Protean III (Biorad) under constant current (30 mA) for 2 h. The gel was stained with Coomassie blue R250 and destained with a mixture of methanol-acetic acid-water (20:7:73; v/v/v). In-gel PNGase F and tryptic digestion was performed by excising gel pieces that were first in-gel N-deglycosylated using PNGase F. Trypsin was then used for in-gel proteolysis after extraction of released N-glycans as previously described (26) . In an independent experiment, gel pieces were incubated only with trypsin. Peptides were dissolved in 0.1 % TFA and an aliquot was desalted using RP C18 Zip-Tip (Millipore) and eluted with 60 % acetonitrile in water containing 0.1 % TFA and 10 mg/mL α-cinnamic acid, i.e. the matrix for MALDI-MS analysis. Matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) experiments were carried out on a Voyager Elite DE-STR Pro instrument (Perseptive Biosystems, Framingham, MA) in reflectron mode with delayed extraction. Samples preparation is detailed in the supporting material section. carried out according to a standard protocol that follows chlorination of monochlorodimedone (MCD) (20) and detailed in the supporting material section. The activity was calculated by linear fitting of the initial (4-90 s) absorbance decrease at 290 nm. The specific activity was expressed as units (i.e. ΔAbs 290 /min) per mg of protein.
Electrospray tandem mass spectrometry (nano-ESI-MS/MS)-
MPO-mediated oxidation of low-density lipoprotein (LDL) was carried out as previously described (8) . LDL oxidation by the MPO / H 2 O 2 / Cl -system was followed by an ELISA. The latter was based on a mouse monoclonal antibody (Mab AG9) that specifically recognizes oxidized APO B-100 on LDL and on staining with an anti-mouse immunoglobulin G coupled with alkaline phosphatase (7). For details, see supporting material section. The generation of ROS mediated by MPO in endothelial cells (Eahy926 cells) was measured by a fluorescent probe. The fluorescent dyes H 2 DCF-DA and Bodipy ® were purchased from Invitrogen (Carlsbad, CA). Eahy926 cells were incubated with 20 µmol/L dichloro-dihydrofluorescein diacetate (H 2 DCF-DA) for 30 min. at 37°C in the dark before stimulation with r-MPO (10 ng/mL). After 30 min., cells were rinsed and the intracellular oxidation of H 2 DCF by ROS was quantified by measuring the DCF fluorescence at 520 nm (λ exc. = 485 nm) with a Fluoroskan Ascent fluorimeter (Thermo Scientific, Waltham, MA). The protein concentration was measured by the Bradford method after lysis in 1 M NaOH and the fluorescence was expressed as relative fluorescence in arbitrary units per mg protein.
RESULTS

Structure of N-glycans released by PNGase F.
The general strategy employed for glycosylation analysis is outlined in supporting material 1. The glycan structures were determined after tryptic digestion of the reduced carboxamidomethylated proteins. Glycopeptides were enriched by Con A-immobilized affinity chromatography, and fractionated and analyzed by RP-C18 HPLC. Glycopeptides as well as their Ndeglycosylated forms were then identified by MALDI-MS. Released glycans were separated from the peptide moiety using a C18 Sep-Pak cartridge, permethylated and profiled by MALDI-MS. The amino-acid sequences of Ndeglycosylated peptides were finally obtained by Q/TOF tandem mass spectrometry (MS/MS).
MALDI-MS analysis of N-glycans released by
PNGase F. The first part of this study has focused on the general glycosylation pattern of both MPO forms. Data presented in Table 1 and Figure 1 clearly indicate that both h-MPO and r-MPO are characterized by the presence of highmannose structures (Hex 3-7 HexNAc 2 ) accompanied by variable proportions of biantennary and triantennary structures, with the latter less abundant. These results are in agreement with the currently accepted model of eukaryotic N-glycan biosynthesis. The major difference between the two MPO forms concerns the occurrence of higher amount of complextype glycans in r-MPO (Fig. 1B) Table 2 , h-MPO is characterized by a high abundance of 2-linked mannose (relative abundance = 1.00), which is related to the presence of high-mannose structures and biantennary structures. This abundance is additionally confirmed by the high by guest on January 1, 2018 http://www.jbc.org/ Downloaded from proportion of t-mannose (0.56) and of 3,6-linked mannose (0.22). These data are congruent with those obtained by the MALDI mass glycoprofiling. Moreover, the very low level of 2,4 and 2,6 linked mannose (respectively, 0.03 and 0.11) confirms the low abundance of triand/or tetraantennary structures. The presence of t-fucose (0.17) concomitantly with 4,6-linked GlcNAc (0.01) confirms the presence of (α1-6)-core-fucosylated glycans. Concerning bi-and triantennary complex glycans, 3-and 6-linked galactose (0.15 and 0.14) are well represented as compared to terminal galactose (0.08), underlining the predominance of sialylated towards non-sialylated complex structures. The same analysis performed on r-MPO is summarized in Table 2 . As a matter of fact, 2-linked mannose, t-mannose and 3,6-linked mannose are also abundant (1.00, 1.32 and 1.06, respectively), confirming the presence of major high-mannose and biantennary structures. The low amount of 2,4-and 2,6-linked mannose (0.035 and n.d., respectively) is congruent with a low level of tri-and/or tetraantennary structures. However, the proportion of terminal galactose (0.56) and of 3-linked galactose (0.17) is in favour of terminal galactose. This is related to the predominance of non sialylated galactose illustrated by the abundance of dHex 1 Hex 5 HexNAc 4 (m/z 2245). Moreover, 6-linked galactose is absent, which is in accordance with the absence of (α2-6)sialyltransferase in CHO cell line (28) . Site-specific N-glycosylation. After investigation of the general glycosylation profile of both MPO forms, site by site analysis of glycosylation was performed. For this reason, glycopeptides from r-MPO have been isolated from the tryptic digest by Con A-affinity chromatography that allows separation of glycopeptides from peptides. Elution with 10 and 300 mM of α-methyl-Dglucose allowed differentiation between low and high affinity fractions (see supporting material 2). Both fractions were separated by RP-C18 HPLC giving at least seven defined peaks in the chromatogram at 45. . This allowed correlation between glycopeptides and fractions of the chromatograms. Consequently, the total tryptic digests of both MPO forms were injected in the same chromatographic system and fractions around the selected time of glycopeptides (45.5, 55.2, 65.8, 81.0, 86.4 min.) were analyzed by MALDI-TOF MS. Fractions containing glycopeptides were digested using PNGase-F to characterize, on one hand, the carbohydrate composition of each glycosylation site and to identify, on the other hand, the peptide sequence. The site by site N-glycan composition of h-MPO and r-MPO is presented in Figure 3 and detailed in supporting material 5. The site-specific N-glycosylation appears to be relatively conserved in r-MPO. Starting from the N-terminal residue, the first site is Asn323 being glycosylated with a variety of complex-type hyposialylated structures in r-MPO. However, During first experiments, the propeptide of r-MPO could not be isolated. However, the Nterminal amino acid sequencing of recombinant MPO demonstrated the (partial) presence of the pro-peptide S(A 49 )-P(A 50 )-P 51 -A 52 -V 53 , as previously described (Moguilevsky et al., 1991) . Analysis of the putative glycosylation at Asn139 by direct LC/ESI/MSMS analyses revealed the presence of glycan structures in the propeptide. In-gel analysis of peptidic sequence and relative site occupancy. The in-gel analysis of MPO allowed the identification of band sequences as well as the estimation of the relative occupancy of glycosylation sites. As illustrated in supporting material 6, the electrophorograms of both MPO forms showed three bands after denaturation (57 kDa, 37 kDa and 15 kDa) with the two upper bands corresponding to the heavy and the 15 kDa band to the light chain.
To estimate the relative occupancy of each site, the peptide mass fingerprints of the heavy chain of both MPO forms were determined (upper band, 57 kDa). The signal intensity of the non-glycosylated peptides containing each glycosylation site was measured before and after PNGase F treatment and normalized to that of the abundant signals at m/z 1508 and 1973, that are known to lack a glycosylation site. The relative occupancy (%) was estimated using the following formula:
Relative occupancy (%) = 100-(100 / Int 1 x Int 2 ) with Int 1 and Int 2 representing the relative signal intensities before and after incubation with PNGase F. As summarized in Table 3 , h-MPO is characterized by about 100 % occupancy of all N-glycosylation sites except for Asn 729 where no occupancy could be calculated. Concerning r-MPO, a relative occupancy of 100 % was calculated for Asn323 and Asn483 while Asn355, Asn391 and Asn729 had a relative occupancy of 58, 96 and 75 %, respectively.
Deglycosylation of MPO and functional analysis.
Considering the established glycosylation profile of MPO, the impact of the deglycosylation on the enzyme activity was further studied. Actually, the deglycosylation of MPO was followed by LC/ESI/MSMS (supporting material 7). According to the recovery of MPO sequences obtained in the enriched glycopeptide fraction, Asn355 and Asn391 were deglycosylated. Furthermore, the samples were also analysed by LC/ESI/MS and the total ion chromatogram (TIC) extracted at the masses corresponding to the deglycosylated peptides. Obtained data suggest that only N355 was totally deglycosylated as the peak disappeared in the chromatogram corresponding to MPO treated by glycosidases (supporting material 8).
Concerning the functional analysis, the activity of MPO was measured in three different in vitro models. As shown in Fig. 4A , there was a significant decrease (37 %) in chlorination activity of deglycosylated r-MPO (MPOdegly, 39 ± 3 U/mg, 63 %) as compared to untreated r-MPO (63 ± 4 U/mg, 100 %) and MPO treated in the absence of glycosidases (MPO37°, 55 ± 2 U/mg, 56 %). Similarly, a comparable decrease was monitored in MPO-mediated LDL oxidation (72 ± 12 % versus 100 ± 5 %, P < 0.05; Fig. 4B ). Finally, ROS production induced by MPO in endothelial cells was measured. A first experiment was carried out with an inactive form of recombinant MPO (Gln257Thr) that showed a background level production similar to native r-MPO (supporting material 9). However deglycosylated r-MPO exhibited a 50 % decrease in ROS generation as compared to untreated MPO (Eahy926, Fig. 4C ).
DISCUSSION
The carbohydrate moiety of glycoproteins plays important roles in biosynthesis (targeting and processing) and influences properties of the mature protein such as solubility, stability, immunogenicity or molecular recognition (29) (30) (31) (32) . As far as MPO is concerned, the catalytic activity of the enzyme is located in the heme pocket deeply embedded in the inner protein core (33) . So far, post-translational modifications (e.g. glycosylation) occurring at the protein surface were thought to be irrelevant for the enzymatic activity. However, there is nowadays a growing body of evidence that MPO might contribute to the inflammatory process by interacting with neutrophils and endothelial cells. Leucocyte MPO was shown to act as an autocrine stimulator of PMN, thereby promoting degranulation, integrin expression and NAPDH oxidase activation (15) , and recombinant MPO was demonstrated to increase LDL oxidation at the surface of endothelial cells in the absence of any stimulating factor (16) .
Comprehensive analysis and comparison of glycosylation of h-MPO and r-MPO revealed striking observations. N-glycans are largely represented by high-mannose structures in hby guest on January 1, 2018 http://www.jbc.org/ Downloaded from MPO and minor biantennary complex glycans are largely sialylated. On the other hand, r-MPO is characterized by the abundance of 2-linked mannose and t-mannose also reflecting oligomannose and biantennary structures. These observations reflect some conservation of the Nglycans types in the recombinant form. However, the sialylation of r-MPO is markedly increased. There is a larger amount of complex structures in r-MPO that might be related to its processing. Indeed, h-MPO is rapidly synthesized in the early stages of the promyelocytic maturation and is stored in the primary granules of PMNs (3) . Such a processing is not in favour of the synthesis of complex structures. In contrast, r-MPO is slowly processed in CHO cell lines in a mannosesupplemented medium that allows maturation of the protein through an efficient N-glycan synthesis and promotes synthesis of complex glycan structures (34) .
The present study also demonstrated for the first time occupancy of all five Asnglycosylation sites (323, 355, 391, 483 and 729) on the heavy polypeptide of both MPO forms. The occupancy of four of them was confirmed by crystallographic analysis (323, 355, 391 and 483) (20) and biochemical studies (18, 20, 35) . Thus, in accordance with crystallographic data (2, 33) , dimeric h-MPO has at least 3 glycosylation sites that are able to interact with receptors or other membrane proteins (Asn355, 391 and 729). Asn323 and 483 contribute to dimer stabilisation due to their location at the interface (2, 20, 33) . The present site-by-site Nglycosylation analysis demonstrates that most of the N-glycosylation sites are well conserved. Concerning the occupancy, in-gel experiments indicated partial glycosylation at Asn355, 391 and 729 in r-MPO while h-MPO showed a total (100 %) occupancy of these sites.
Recombinant monomeric MPO (N-terminal Ala49) carries part of the propeptide (10) that includes glycosylated Asn139 (10). This was confirmed by N-terminal sequencing and LC/ESI/MSMS showing the presence of Asn139 in the glycopeptide fraction. Surprisingly, the enzyme activity was affected by N-glycosylation. MPO is characterized by rigid heme architecture, as the heme is covalently linked to Asp260, Glu408 and Met409 and the proximal histidine (His502) is hydrogen-bonded with an asparagine (Asn587). The roof of the distal heme pocket is formed by an arginine (Arg405) and the distal histidine (His261) that is close to calciumbinding Asp262. Additional Ca 2+ -binding residues are found in the sequence Thr334-Ser335-Phe336-Val337-Asp338-Ala339-Ser340 that is connected to Asn355 by a α−helix (20, 33) . Thus residues in heme to protein linkages and Ca 2+ -binding are positioned both in the N-and C-terminal region of the polypeptide (light and heavy subunit in h-MPO). Since glycosylation affects the enzymatic activity, it is reasonable to assume that modification of the overall protein structure is also reflected by (minor) changes in the heme cavity architecture and/or the access channel. Indeed, despite the long incubation time that also affects MPO activity to some extent, deglycosylation caused a significant decrease in activity. Such an effect could have important consequences on the in vivo activity of MPO. For example, it is generally accepted that MPO is adsorbed on LDL and specifically oxidizes the apolipoprotein B100 (7, 36) . This interaction might be modulated by glycosylation since deglysosylated MPO is less active in LDL oxidation than native peroxidase. In this model, decreased activity could be caused by alterations of heme or substrate channel architecture or by modification of the interaction with the substrate. In case of MPO-mediated ROS production in endothelial cells, deglysosylation clearly reduced the enzymatic activity of r-MPO since the heme lacking glycosylated variant could not mediate ROS production.
In summary, the macro-and microheterogeneity of N-glycans is well conserved in recombinant monomeric MPO as compared to the mature dimeric leucocyte protein (h-MPO). All predicted N-asparagine glycosylation sites are occupied and oligomannose structures are dominant among the N-glycans. Recombinant MPO carries more complex structures like biand triantennary N-glycans. Deglycosylation of especially Asn355 lowers enzyme activity, suggesting the importance of intact glycosylation for enzyme activity. Fig. 1 . MALDI-TOF mass spectrum of permethylated N-glycans derived from human mature myeloperoxidase (h-MPO) (A) and recombinant myeloperoxidase (r-MPO) (B). . Glycopeptides from the different fractions were deglycosylated using PNGase F. The peptidic aglycone was purified on to a C18 Zip-tip and then analysed by nano-ESI-MS/MS under 40 eV as collision energy. The Asn residues were converted in aspartic residues after PNGase F treatment (For detailed information and raw data, see supplementary materials 2 & 3). Fig. 3 . Comparison of the micro-heterogeneity of N-glycans of mature dimeric myeloperoxidase (h-MPO) and recombinant myeloperoxidase (r-MPO). Colors and form-codes are as in Table 1 . 
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